01.30.26 -- The 5-Layer Fix For AI Failure In Pharmaceutical Manufacturing

Explore how manufacturers can turn sustainability challenges into strategic advantages through smarter energy use, regulatory insight, and emerging innovations.

Understanding the complex effects of inflation, recession, and regulatory shifts is key to navigating the challenges faced by the biopharmaceutical manufacturing sector and ensuring its continued growth.

Proactively improve your cleanroom strategy. Gain actionable insights on leveraging Environmental Monitoring data, optimizing personnel, and managing residue to enhance contamination control.

Delve into how Annex 1 reshapes aseptic process validation, as well as into risk reduction by design and why isolators are redefining modern sterile manufacturing standards.

Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting methods and excipients to achieve the desired stability.

Document review is a hidden bottleneck in biopharma. Discover how inefficiencies in this critical process can delay drug development and what you can do to accelerate time to market.

Insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.

Enhance your understanding of liver organoids and their pivotal role in enhancing DILI risk prediction through the use of advanced Organ-Chip technology.

CDMO audits focus on compliance, quality, performance, and relationships to reduce risk, ensure clear documentation, and align customer expectations with CDMO capabilities.

An optimized nest design for pre-fillable cartridges was designed using numerical simulation and data analytics to improve efficiency in pharmaceutical production.

Here, we review a technology that has been demonstrated to significantly reduce the time required for protein binding determination when compared with the rapid equilibrium dialysis method.

Manufacturing complex and highly potent ADC treatments presents unique challenges. Get an insider look at how these treatments make it from development to commercialization.

Leveraging the experience and specialized technology of a reliable CDMO partner is essential to ensure your sterile injectable therapeutic's safety and quality while delivering at speed.